Browse 472 Federal Consumer Protection Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Consumer Protection grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| March 31st, 2021 |
Development of Advanced Analytical Methods for the Characterization of Iron Carbohydrate Complex - Ferric Derisomaltose (U01) Clinical Trials Not Allowed |
Food and Drug Administration |
| March 18th, 2021 |
Development of a model selection method for population pharmacokinetics analysis by deep-learning based reinforcement learning (U01) Clinical Trials Not Allowed |
Food and Drug Administration |
| March 15th, 2021 |
Quantify the expression of metabolizing enzymes and transporter proteins in lung, eye and skin tissue in relevant animal models and humans (U01) Clinical Trial Not Allowed |
Food and Drug Administration |
| February 18th, 2021 |
National Food and Nutrient Analysis Program (U01) Clinical Trial Not Applicable |
Food and Drug Administration |
| March 15th, 2021 |
Computational Fluid Dynamics (CFD) Models to Aid the Development of Generic Inhalation Products (U01) Clinical Trials Optional |
Food and Drug Administration |
| March 15th, 2021 |
Physiologically Based Pharmacokinetic (PBPK) Models of Oral Absorption to Simulate the Results of Bioequivalence Studies (U01) Clinical Trials Optional |
Food and Drug Administration |
| February 12th, 2021 |
Renewal - Strengthen and Promote the Role of Local Health Departments in Retail Food Safety Regulation (U50 Clinical Trial Not Allowed |
Food and Drug Administration |
| May 21st, 2021 |
Minor Use Minor Species Development of Drugs (R01) Clinical Trials Not Allowed |
Food and Drug Administration |
| March 25th, 2021 |
Development of Methods to Evaluate the Impact of Design Differences to the User Interface of Generic Drug-Device Combination Products in Comparison to their Reference Listed Drugs (U01) Clinical Trials Optional |
Food and Drug Administration |
| February 12th, 2021 |
Renewal - Research, Education, and Outreach on Botanical Natural Products (U01) Clinical Trial Not Allowed |
Food and Drug Administration |
| February 18th, 2021 |
Physiologically-based pharmacokinetic (PBPK) models to aid the development of generic dermatological products (U01) Clinical Trials Optional |
Food and Drug Administration |
| June 11th, 2021 |
Drug Development Tools Research Grants (U01 Clinical Trial Optional) |
Food and Drug Administration |
| January 22nd, 2021 |
Development of a model selection method for population pharmacokinetics analysis by deep-learning based reinforcement learning |
Food and Drug Administration |
| February 1st, 2021 |
Renewal - Cooperative Agreement to Support Shellfish Assistance Project (U01) Clinical Trial Not Allowed |
Food and Drug Administration |
| February 1st, 2021 |
Renewal - Federal and University Partnership to Improve the Safety of Seafood from the Gulf of Mexico (U19) Clinical Trials Not Allowed |
Food and Drug Administration |
| September 29th, 2021 |
Expanding the Opioids System Model to more comprehensively incorporate fentanyl, stimulants use, polysubstance use and associated outcomes. |
Food and Drug Administration |
| March 9th, 2021 |
Dermal Physiologically-Based Pharmacokinetic (PBPK) Models Accounting for the Absorption and Evaporation of Vehicle/Co-Solvent Following the Application of Generic Dermatological Products |
Food and Drug Administration |
| January 11th, 2021 |
Impulse Oscillometry Endpoint Sensitivity to Regional Lung Function Changes using Computational Fluid Dynamics (CFD) |
Food and Drug Administration |
| February 1st, 2021 |
Quantify the expression of metabolizing enzymes and transporter proteins in lung, eye and skin tissue in relevant animal models and humans |
Food and Drug Administration |
| January 29th, 2021 |
U.S. Mission Turkey Grants Program |
Bureau of European and Eurasian Affairs |
|
| May 14th, 2021 |
SmartTots (Strategies for Mitigating Anesthesia-Related neuroToxicity in Tots) Public-Private Partnership |
Food and Drug Administration |
| May 14th, 2021 |
Analgesic, Anesthetic and Addiction Clinical Trials Innovations, Opportunities, and Networks (ACTTION) |
Food and Drug Administration |
| August 23rd, 2021 |
CFD Models to aid the development of generic inhalation products |
Food and Drug Administration |
| July 14th, 2020 |
Pool Safely Grant Program |
Consumer Product Safety Commission |
| October 14th, 2020 |
Development of Standard Core Clinical Outcomes Assessments (COAs) and Endpoints (UG3/UH3 Clinical Trial Optional) |
Food and Drug Administration |
| October 13th, 2020 |
Renewal-Harmonization of Technical Requirements for Pharmaceuticals for Human Use (U01) Clinical Trials Not Allowed |
Food and Drug Administration |
| March 18th, 2021 |
Implementation of the National Evaluation System for Health Technology (NEST) Coordinating Center (CC) |
Food and Drug Administration |
| May 11th, 2021 |
PBPK Models of Oral Absorption to Simulate the Results of Bioequivalence Studies |
Food and Drug Administration |
| May 11th, 2021 |
PBPK Models to Aid the Development of Generic Dermatological Products |
Food and Drug Administration |
| May 11th, 2021 |
Development of methods for evaluating the impact of small design differences in the user interface of drug-device combination products on generic substitutability |
Food and Drug Administration |
| June 23rd, 2020 |
CBER FY20 FOA for AAV vector manufacturing for diseases affecting very small populations (R01) Clinical Trial Not Allowed |
Food and Drug Administration |
| June 8th, 2020 |
Drug Development Science Support (U01) Clinical Trials Optional |
Food and Drug Administration |
| June 1st, 2020 |
Cooperative Agreement to Support an Evidence-based Clinical Practice Guideline for the Treatment of Acute Dental Pain (U01) Clinical Trials Not Allowed |
Food and Drug Administration |
| June 1st, 2020 |
Cooperative Agreement to Support FDA Land and Water Initiative (U01) Clinical Trial Not Allowed |
Food and Drug Administration |
| See Grant Text |
CBER FY20 FOA for AAV vector manufacturing for diseases affecting very small populations (R01) Clinical Trial Not Allowed |
Food and Drug Administration |
| April 9th, 2020 |
GRRI CESU: Partnership to Study Recreation Trends and Increase Access- RTCA |
National Park Service |
| May 22nd, 2020 |
Stopping the Spread of Disinformation - Training Emerging Journalists |
US Mission to India |
| April 16th, 2020 |
Supporting business and professional associations in Azerbaijan |
Azerbaijan USAID Baku |
| May 18th, 2020 |
Incorporating cost effectiveness & societal outcomes into FDA opioids model (U01) Clinical Trials Not Allowed |
Food and Drug Administration |
| See Grant Text |
Drug Development Science Support (U01) |
Food and Drug Administration |
